(Note: For PDF File Swipe To The End Of Article)
Introduction
The digestive system does much more than break down food. It absorbs essential nutrients, supports immune function, maintains fluid balance, and supplies the body with the energy needed for everyday life. When the digestive tract becomes chronically inflamed, these essential processes can be disrupted, affecting a person's physical health, emotional well-being, and quality of life.
One important condition responsible for chronic intestinal inflammation is Crohn’s disease, a type of inflammatory bowel disease (IBD). It can affect any part of the gastrointestinal tract, from the mouth to the anus, although it commonly involves the end of the small intestine and the beginning of the large intestine.
Crohn’s disease is a long-term condition characterized by periods of active inflammation, called flares, and periods when symptoms improve or disappear, called remission. Some patients experience relatively mild symptoms for years, while others develop persistent inflammation, intestinal narrowing, fistulas, abscesses, nutritional deficiencies, or complications requiring surgery.
The exact cause of Crohn’s disease remains incompletely understood. Research suggests that genetic susceptibility, immune-system activity, environmental influences, and interactions with the intestinal microbiome contribute to its development.
Although there is currently no universally available cure, treatment has advanced considerably. Medicines that reduce inflammation, regulate immune activity, and target specific inflammatory pathways can help control symptoms, heal intestinal tissue, and reduce complications. Nutrition support, monitoring, and surgery when necessary also play important roles.
This article explains Crohn’s disease in detail, including its definition, causes, risk factors, pathophysiology, types, signs and symptoms, diagnostic investigations, treatment options, complications, dietary management, nursing care, and long-term outlook.
1. What Is Crohn’s Disease?
Crohn’s disease is a chronic inflammatory disorder belonging to the group of conditions known as inflammatory bowel disease.
It can affect any part of the gastrointestinal tract, but common sites include:
- The terminal ileum, which is the final part of the small intestine.
- The colon, or large intestine.
- The region where the small intestine joins the large intestine.
- Both the small and large intestines.
Inflammation may occur in separate areas, with healthy-looking sections of intestine between affected regions. These are often called skip lesions.
A characteristic feature of Crohn’s disease is that inflammation may extend through multiple layers of the intestinal wall. This is known as transmural inflammation. It helps explain why some patients develop deep ulcers, strictures, fistulas, and abscesses.
Crohn’s disease is not contagious. It cannot be transmitted through ordinary contact, sharing food, touching, or being near someone who has the condition.
It is also different from irritable bowel syndrome (IBS). IBS can cause abdominal pain and altered bowel habits, but it does not produce the characteristic intestinal inflammation and tissue damage associated with Crohn’s disease.
Crohn’s disease may begin at any age, although many people are diagnosed during adolescence or early adulthood. It can also develop in children and older adults.
2. Understanding the Digestive System
To understand Crohn’s disease, it helps to know how the digestive tract normally functions.
The digestive tract is a continuous tube that processes food, absorbs nutrients, and eliminates waste. Different sections perform specialized tasks.
A. Mouth and esophagus
Digestion begins in the mouth, where food is chewed and mixed with saliva. The esophagus then transports swallowed food to the stomach.
Crohn’s disease can occasionally affect the mouth or upper digestive tract, although these are less common sites.
B. Stomach
The stomach mixes food with acid and digestive enzymes. It helps break down proteins and prepares food for further digestion in the small intestine.
Inflammation affecting the stomach or upper gastrointestinal tract can cause pain, nausea, or other symptoms in some patients.
C. Small intestine
The small intestine is the main site of nutrient absorption. It consists of the duodenum, jejunum, and ileum.
The terminal ileum is a particularly common location for Crohn’s disease. Inflammation here can interfere with the absorption of vitamin B12 and bile acids.
D. Large intestine
The colon absorbs water and electrolytes and helps form stool.
Crohn’s disease involving the colon can cause diarrhea, abdominal discomfort, rectal bleeding, and urgency.
E. Rectum and anus
The rectum stores stool before elimination. The anal region contains structures important for bowel control.
Crohn’s disease may cause fissures, abscesses, fistulas, and other perianal complications.
Because Crohn’s disease can involve different sections of the digestive tract, its symptoms and complications vary considerably between patients.
3. Causes of Crohn’s Disease
The precise cause of Crohn’s disease is not fully known. It is not caused by one specific food, one infection, or one behavior.
Current understanding suggests that Crohn’s disease develops through an interaction between genetic susceptibility, immune responses, intestinal microorganisms, and environmental influences.
A. Immune-system dysfunction
The immune system protects the body against harmful organisms and helps maintain tissue health.
In Crohn’s disease, immune responses within the intestinal environment become abnormal or poorly regulated. This leads to persistent inflammation that can damage the intestinal lining and deeper tissues.
The immune system is not simply attacking food or one specific organism. Instead, the condition involves a complex disturbance in how the body interacts with intestinal microbes and its own tissues.
B. Genetic factors
Crohn’s disease can occur in families. People with a close relative who has Crohn’s disease or another form of IBD have a higher risk than those without such a family history.
Researchers have identified numerous genetic variants associated with immune regulation, intestinal barrier function, and microbial recognition.
However, having a genetic susceptibility does not mean a person will definitely develop Crohn’s disease. Environmental and other biological factors also contribute.
C. Intestinal microbiome
The intestine contains a large community of microorganisms, collectively called the gut microbiome.
These organisms participate in digestion, metabolism, and immune-system development.
Differences in the composition and activity of the intestinal microbiome have been associated with Crohn’s disease. Researchers continue to investigate how these changes contribute to inflammation and whether targeted microbiome treatments can improve outcomes.
D. Intestinal barrier abnormalities
The intestinal lining acts as a barrier between the contents of the gut and the body's internal tissues.
When this barrier functions abnormally in susceptible individuals, interactions between intestinal microbes and immune cells may promote inflammation.
This process is complex, and it is not fully understood whether barrier changes initiate disease or develop partly as a consequence of inflammation.
E. Environmental factors
Environmental influences may affect the risk of developing Crohn’s disease or experiencing more severe disease.
Examples include smoking, certain medication exposures, dietary patterns, and broader environmental changes. The strength of evidence varies for different factors.
Importantly, Crohn’s disease is not caused by personal weakness, poor character, or a failure to manage stress.
Stress may worsen symptoms or make living with the disease more difficult, but it is not considered the sole cause of Crohn’s disease.
4. Risk Factors for Crohn’s Disease
Several factors are associated with an increased likelihood of developing Crohn’s disease or experiencing a more complicated course.
A. Family history
A family history of Crohn’s disease or ulcerative colitis increases risk. However, many patients have no known affected relatives.
B. Age
Crohn’s disease often begins during adolescence or early adulthood, but it can occur at any age.
C. Smoking
Smoking is an important modifiable risk factor. It is associated with a higher risk of Crohn’s disease and, in people who already have the condition, can contribute to more difficult disease control and an increased risk of recurrence after surgery.
Stopping smoking is an important part of long-term care.
D. Certain medications
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may worsen gastrointestinal symptoms or contribute to intestinal injury in some people.
They are not established as the single cause of Crohn’s disease, and their effects vary. Patients should discuss appropriate pain relief with their healthcare professional.
E. Environmental and geographic influences
Crohn’s disease is more commonly diagnosed in some industrialized regions, although its prevalence is increasing in many other parts of the world.
These patterns suggest that environmental factors may influence risk, but they do not identify a single cause.
F. Previous gastrointestinal infections
Some infections may trigger temporary intestinal inflammation or complicate existing Crohn’s disease. Researchers continue to investigate whether certain microbial exposures influence disease development in susceptible individuals.
A history of ordinary gastroenteritis does not, by itself, mean that someone will develop Crohn’s disease.
5. Pathophysiology: How Crohn’s Disease Develops
The pathophysiology of Crohn’s disease involves an abnormal interaction between the intestinal immune system, the gut microbiome, and the intestinal barrier.
In susceptible individuals, immune responses become dysregulated and lead to persistent inflammation.
A. Initial immune activation
Immune cells recognize microbial components and other signals within the intestine. In Crohn’s disease, these responses may become excessive, poorly controlled, or insufficiently resolved.
Inflammatory signaling molecules recruit additional immune cells and sustain the inflammatory process.
B. Intestinal tissue injury
Persistent inflammation damages the intestinal lining. Ulcers may form, and inflammation can extend into deeper layers of the bowel wall.
The affected tissue may become swollen, fragile, and less effective at absorbing nutrients.
C. Transmural inflammation
Unlike inflammation limited primarily to the inner lining, Crohn’s disease can involve the full thickness of the intestinal wall.
This can result in complications such as:
- Deep ulcers.
- Thickening of the bowel wall.
- Narrowing of the intestinal passage.
- Fistula formation.
- Abscesses.
- Adhesions or other changes associated with chronic inflammation and surgery.
D. Intestinal narrowing
Repeated inflammation and healing may produce scar tissue. The combination of inflammation and fibrosis can narrow the intestinal passage, creating a stricture.
A severe stricture may obstruct the movement of food and intestinal contents, causing cramping, abdominal distension, vomiting, and difficulty passing stool or gas.
E. Malabsorption
Inflammation affecting the small intestine can reduce nutrient absorption.
For example, terminal ileal disease may interfere with vitamin B12 absorption and the recycling of bile acids. Extensive small-bowel disease or surgery can contribute to iron deficiency, weight loss, and other nutritional problems.
F. Systemic inflammation
Inflammatory signals can affect organs outside the digestive tract. Crohn’s disease may therefore be associated with joint inflammation, eye disease, skin problems, liver or bile-duct disorders, and other extraintestinal manifestations.
This explains why Crohn’s disease is considered a systemic inflammatory condition rather than simply a problem of diarrhea.
6. Types and Patterns of Crohn’s Disease
Crohn’s disease is classified according to the location of inflammation, the pattern of disease behavior, and the presence of complications.
A. Ileal Crohn’s disease
This form primarily affects the ileum, especially its terminal portion.
Symptoms may include pain in the lower right abdomen, diarrhea, weight loss, and nutritional deficiencies.
Narrowing of the terminal ileum can cause obstructive symptoms.
B. Colonic Crohn’s disease
This form primarily affects the large intestine.
Patients may experience diarrhea, abdominal cramps, urgency, and rectal bleeding.
Colonic disease may sometimes resemble ulcerative colitis, so clinical assessment, endoscopy, biopsies, and imaging are important for distinguishing the conditions.
C. Ileocolonic Crohn’s disease
Both the terminal ileum and the colon are affected.
This is a common pattern and may produce a combination of small- and large-bowel symptoms.
D. Upper gastrointestinal Crohn’s disease
Crohn’s disease can affect the stomach or upper small intestine, although this is less common.
Possible symptoms include upper abdominal pain, nausea, vomiting, and reduced appetite.
E. Stricturing disease
In stricturing Crohn’s disease, the bowel becomes narrowed because of inflammation, fibrosis, or both.
Patients may develop recurrent cramping, bloating, vomiting, and symptoms of partial or complete intestinal obstruction.
F. Penetrating disease
Penetrating Crohn’s disease occurs when inflammation extends through the intestinal wall and creates abnormal channels or fistulas.
Fistulas may connect the intestine to another part of the intestine, the skin, the bladder, the vagina, or other structures.
G. Perianal Crohn’s disease
Perianal disease affects the tissues surrounding the anus. It can include fissures, fistulas, abscesses, skin tags, and painful swelling.
This form may require coordinated care from gastroenterologists and colorectal surgeons.
A patient's disease pattern can change over time, so regular reassessment is important.
7. Signs and Symptoms of Crohn’s Disease
Symptoms vary depending on the location and severity of inflammation.
Some patients have intermittent symptoms, while others experience persistent problems that interfere with daily activities.
A. Chronic diarrhea
Diarrhea is one of the most common symptoms. It may result from intestinal inflammation, altered absorption, bile-acid malabsorption, or other mechanisms.
The stool may be watery, frequent, or urgent. Blood may be present, particularly when the colon is involved, but not every patient experiences bloody diarrhea.
B. Abdominal pain
Abdominal pain may result from inflammation, intestinal spasms, ulcers, or narrowing of the bowel.
The location depends on the affected section of the digestive tract. Pain in the lower right abdomen is common when the terminal ileum is involved.
Severe or persistent pain, especially with vomiting or abdominal distension, requires prompt medical assessment.
C. Weight loss
Patients may lose weight because of reduced appetite, pain after eating, diarrhea, malabsorption, or increased energy requirements associated with chronic inflammation.
Unintentional weight loss should be evaluated rather than assumed to be a normal feature of the disease.
D. Fatigue
Fatigue can result from chronic inflammation, anemia, nutrient deficiencies, poor sleep, medication effects, and the physical burden of living with a chronic illness.
It may persist even when intestinal symptoms are relatively mild.
E. Fever
Fever may occur during active inflammation or when complications such as an abscess develop.
A new fever, especially with worsening abdominal pain or chills, requires prompt assessment because infection may be present.
F. Loss of appetite
Abdominal discomfort, nausea, fatigue, and fear of triggering symptoms can reduce appetite.
Persistent poor intake may contribute to malnutrition and weight loss.
G. Rectal bleeding
Blood in the stool may occur when Crohn’s disease affects the colon or rectal region.
Rectal bleeding can also have other causes, including hemorrhoids, fissures, infections, and other intestinal disorders. It should be evaluated, particularly if it is persistent or substantial.
H. Mouth ulcers
Some patients develop painful ulcers in the mouth. These may occur alongside intestinal flares or as part of the broader inflammatory condition.
I. Perianal symptoms
Perianal Crohn’s disease can cause pain, swelling, drainage, skin irritation, or recurrent infections near the anus.
An abscess may cause severe pain and fever and can require urgent drainage.
J. Symptoms of intestinal obstruction
A stricture may cause:
- Cramping abdominal pain.
- Bloating and abdominal distension.
- Nausea and vomiting.
- Reduced passage of stool or gas.
Severe or progressive symptoms can indicate an obstruction and require emergency evaluation.
8. Extraintestinal Manifestations
Crohn’s disease can affect organs outside the gastrointestinal tract. Some manifestations follow intestinal disease activity, while others may develop independently.
A. Joint problems
Some patients experience joint pain, stiffness, or inflammatory arthritis.
Large-joint symptoms may fluctuate with bowel inflammation, while other forms of arthritis can follow a different course.
B. Eye inflammation
Crohn’s disease may be associated with episcleritis, scleritis, or uveitis.
Eye pain, redness, sensitivity to light, or blurred vision requires prompt medical evaluation, particularly when uveitis or other serious eye inflammation is suspected.
C. Skin conditions
Associated skin conditions include erythema nodosum, which causes tender red nodules, and pyoderma gangrenosum, a less common condition involving painful skin ulcers.
Not every skin problem in a person with Crohn’s disease is caused by the disease or its treatment.
D. Liver and bile-duct disorders
Some patients develop abnormal liver tests or associated hepatobiliary conditions. These may arise from inflammation, medication effects, fatty liver disease, gallstones, or less common immune-related conditions.
E. Kidney and gallbladder complications
People with Crohn’s disease may have an increased risk of certain kidney stones, particularly when intestinal disease or surgery alters fluid and oxalate absorption.
Gallstones may also occur, especially in patients with terminal ileal disease or ileal resection.
F. Anemia
Anemia can result from iron deficiency due to blood loss, vitamin B12 deficiency, chronic inflammation, or other causes.
Identifying the type of anemia is important because treatment differs depending on the underlying mechanism.
9. Complications of Crohn’s Disease
Complications may develop when inflammation is severe, persistent, or associated with structural damage.
A. Intestinal strictures
Chronic inflammation can lead to bowel-wall thickening and scar tissue. The resulting narrowing may cause partial or complete obstruction.
Some strictures improve with medical treatment when inflammation is the main component. Fibrotic strictures may require endoscopic or surgical treatment.
B. Fistulas
A fistula is an abnormal passage connecting two surfaces or organs.
Examples include:
- Enteroenteric fistulas, connecting sections of intestine.
- Enterocutaneous fistulas, connecting the intestine to the skin.
- Enterovesical fistulas, connecting the intestine to the bladder.
- Rectovaginal fistulas, connecting the rectum to the vagina.
- Perianal fistulas, extending around the anus.
Fistulas may cause drainage, recurrent infections, discomfort, or passage of gas or intestinal contents through an abnormal route.
Treatment depends on the fistula's location, complexity, associated abscesses, and the patient's overall condition.
C. Abscesses
An abscess is a collection of pus caused by infection.
In Crohn’s disease, abscesses may develop within the abdomen or around the anus. Symptoms may include fever, localized pain, tenderness, and general illness.
Abscesses often require antibiotics and drainage, depending on their size and location. Immunosuppressive treatment may need to be adjusted while infection is being managed.
D. Malnutrition
Inflammation, diarrhea, reduced intake, and malabsorption can result in inadequate energy and nutrient intake.
Malnutrition may cause muscle loss, weakness, impaired healing, and poorer recovery from illness or surgery.
E. Vitamin and mineral deficiencies
Depending on disease location and severity, patients may develop deficiencies of iron, vitamin B12, folate, vitamin D, calcium, zinc, and other nutrients.
Testing should be guided by the clinical situation and the patient's history.
F. Osteoporosis and bone weakness
Chronic inflammation, reduced physical activity, malnutrition, vitamin D deficiency, and repeated corticosteroid exposure can contribute to reduced bone density.
Patients at increased risk may need bone-health assessment and preventive measures.
G. Colorectal cancer risk
Long-standing Crohn’s disease involving a substantial portion of the colon can increase colorectal cancer risk.
The risk depends on disease duration, extent, inflammatory burden, family history, and other factors.
Appropriate colorectal cancer surveillance is important for patients whose disease places them at increased risk. The timing and frequency should follow specialist guidance.
H. Psychological effects
Living with a chronic inflammatory disease can contribute to anxiety, depression, social isolation, and reduced quality of life.
Psychological support and treatment should be considered when needed, alongside physical care.
10. Diagnosis of Crohn’s Disease
There is no single test that confirms every case of Crohn’s disease. Diagnosis generally combines the patient's history, physical examination, laboratory tests, stool studies, endoscopy, biopsies, and imaging.
A. Medical history and physical examination
The clinician asks about diarrhea, abdominal pain, weight loss, rectal bleeding, fever, family history, smoking, medication use, and symptoms outside the digestive tract.
The physical examination may assess abdominal tenderness, distension, nutritional status, oral ulcers, skin changes, and perianal abnormalities when appropriate.
B. Blood tests
Blood tests may include:
- Complete blood count.
- C-reactive protein (CRP).
- Erythrocyte sedimentation rate (ESR).
- Iron studies.
- Vitamin B12 and folate.
- Electrolytes and kidney function.
- Liver function tests.
- Albumin and other nutritional markers.
These tests can identify anemia, inflammation, dehydration, or nutritional problems. However, normal inflammatory markers do not completely exclude Crohn’s disease.
C. Stool tests
Stool testing may help identify intestinal infections that can mimic or worsen inflammatory bowel disease.
Fecal calprotectin is a marker of intestinal inflammation that can help distinguish inflammatory bowel disease from conditions such as IBS in appropriate circumstances. It can also be useful for monitoring disease activity.
However, fecal calprotectin is not specific to Crohn’s disease and may be elevated in other conditions.
D. Colonoscopy with biopsy
Colonoscopy allows a clinician to examine the colon and, when possible, the terminal ileum.
The procedure can identify ulcers, inflammation, narrowing, and other abnormalities. Biopsies are collected for microscopic examination.
Biopsy findings may support Crohn’s disease and help distinguish it from other disorders, although no single microscopic feature is present in every patient.
E. Upper gastrointestinal endoscopy
Upper endoscopy may be considered when symptoms or other findings suggest involvement of the esophagus, stomach, or duodenum.
It allows direct visualization and tissue sampling from the upper digestive tract.
F. Cross-sectional imaging
Magnetic resonance enterography (MRE) and computed tomography enterography (CTE) can evaluate sections of the small intestine that may not be accessible during colonoscopy.
Imaging can help identify bowel-wall thickening, inflammation, strictures, fistulas, abscesses, and other complications.
MRI avoids ionizing radiation and may be preferred for repeated assessment when appropriate and available. CT may be particularly useful in urgent situations.
G. Capsule endoscopy
In selected cases, a patient may swallow a small capsule containing a camera to visualize the small intestine.
Capsule endoscopy can detect abnormalities that are difficult to reach using standard endoscopy. However, it may be unsafe when a significant stricture is suspected because the capsule can become trapped.
A clinician may recommend imaging or a patency capsule first.
H. Excluding other conditions
Several disorders can resemble Crohn’s disease, including infectious enteritis, ulcerative colitis, celiac disease, medication-related intestinal injury, intestinal tuberculosis, and other inflammatory or vascular conditions.
The diagnosis should be based on the full clinical picture, especially in regions where intestinal infections such as tuberculosis are important considerations.
11. Crohn’s Disease Versus Ulcerative Colitis
Crohn’s disease and ulcerative colitis are the two major forms of inflammatory bowel disease. They share several symptoms but differ in important ways.
| Feature | Crohn’s disease | Ulcerative colitis |
|---|---|---|
| Possible location | Any part of the gastrointestinal tract | Colon and rectum |
| Distribution | May involve separated areas | Usually continuous inflammation starting in the rectum |
| Depth of inflammation | Can extend through the full bowel wall | Primarily affects the inner lining |
| Small intestine | Frequently involved, especially the terminal ileum | Usually not involved, apart from certain associated patterns |
| Fistulas and abscesses | More characteristic | Less typical |
| Strictures | Can occur | Less common; require careful evaluation |
| Perianal disease | Can be prominent | Less characteristic |
| Surgery | May treat complications but does not eliminate the tendency for disease to recur elsewhere | Removal of the colon can eliminate colonic ulcerative colitis |
Some patients have features that do not clearly distinguish the two conditions. A specialist may initially use an unclassified IBD diagnosis while further information is gathered.
12. Treatment of Crohn’s Disease
The goals of treatment are to reduce inflammation, relieve symptoms, achieve and maintain remission, heal intestinal tissue, prevent complications, preserve nutrition, and improve quality of life.
Treatment is individualized according to disease location, severity, complications, previous treatment response, and patient preferences.
A. Corticosteroids
Corticosteroids, such as prednisone or budesonide in appropriate circumstances, may be used to control certain active flares.
They reduce inflammation relatively quickly, but they are generally not suitable for long-term maintenance because prolonged use can cause serious adverse effects.
Potential complications include osteoporosis, diabetes, weight gain, increased infection risk, cataracts, mood changes, and adrenal suppression.
The objective is to control active inflammation and then reduce and discontinue corticosteroids according to the prescribed plan.
B. Immunomodulators
Some medicines modify immune-system activity and may be used in selected patients.
Examples include azathioprine, mercaptopurine, and methotrexate.
Their onset of action and risks vary. Some are used to maintain remission or as part of a combination regimen, rather than as rapid treatment for a severe acute flare.
Patients require appropriate blood tests and safety monitoring because these medicines can cause adverse effects involving the liver, bone marrow, or other organs.
C. Biologic therapies
Biologic medicines target specific components of the inflammatory process.
Examples include:
- Anti-TNF medicines, such as infliximab and adalimumab.
- Anti-integrin therapy, such as vedolizumab.
- Interleukin-targeting therapies, including ustekinumab and certain IL-23 inhibitors.
These medicines may be used for moderate to severe disease, fistulizing disease, or patients who have not responded adequately to other treatments.
The choice depends on disease characteristics, previous treatment, coexisting conditions, safety considerations, and local availability.
Before starting many biologic therapies, clinicians assess for infections such as tuberculosis and hepatitis B and review vaccination status.
D. Targeted oral medicines
Some small-molecule medicines act on intracellular pathways involved in inflammation. Janus kinase (JAK) inhibitors and other targeted agents have roles in certain inflammatory bowel disease settings, with approved indications varying by medicine and jurisdiction.
Their suitability for Crohn’s disease depends on current regulatory approvals, clinical guidance, previous treatments, and patient-specific risks.
These medicines require appropriate safety screening and monitoring.
E. Aminosalicylates
Aminosalicylate medicines, such as mesalamine, have an established role in some forms of ulcerative colitis but generally have limited effectiveness for most Crohn’s disease presentations.
They should not be assumed to be an effective substitute for appropriate Crohn’s disease therapy.
F. Antibiotics
Antibiotics may be used when a bacterial infection, abscess, or selected fistulizing complication is present.
They are not routinely effective as a general treatment for intestinal inflammation in every patient with Crohn’s disease.
The choice of antibiotic depends on the suspected infection, its location, local resistance patterns, and the patient's clinical condition.
G. Combination therapy
In selected cases, clinicians may combine medicines that work through different mechanisms.
Combination therapy can improve disease control for some patients but may also increase the risk of infections or other adverse effects.
The benefits and risks should be reviewed regularly.
H. Treat-to-target care
Modern management increasingly aims to achieve more than temporary symptom relief.
A treat-to-target approach involves defining treatment goals, monitoring symptoms and objective markers of inflammation, and adjusting therapy when the disease remains active.
Targets may include clinical remission, improvement in inflammatory markers, and healing of the intestinal lining on endoscopy or imaging.
This approach can help identify ongoing inflammation even when symptoms have improved.
13. Surgery in Crohn’s Disease
Surgery may be required when complications cannot be managed adequately with medicines or when urgent problems develop.
Potential indications include:
- Intestinal obstruction due to a stricture.
- Abscesses requiring drainage.
- Complex fistulas.
- Severe bleeding in selected cases.
- Perforation.
- Persistent disease despite appropriate medical treatment.
- Certain cases of dysplasia or cancer.
A. Strictureplasty
Strictureplasty is a surgical procedure that widens a narrowed section of intestine without removing that segment.
It may be useful in selected patients with small-bowel strictures.
B. Bowel resection
A surgeon may remove a diseased or damaged section of intestine and reconnect the healthy ends when appropriate.
However, Crohn’s disease can recur in other parts of the digestive tract or near the surgical connection.
Repeated bowel resections can cause short-bowel syndrome, in which too little functional intestine remains for adequate nutrient and fluid absorption.
C. Fistula surgery
Some fistulas require drainage, repair, or other surgical procedures.
Complex perianal fistulas often require a coordinated approach involving medical therapy and colorectal surgical care.
An abscess usually needs appropriate drainage and infection management before or alongside decisions about immunosuppressive treatment.
D. Is surgery a cure?
Surgery can relieve obstruction, remove severely damaged bowel, or treat complications. However, it does not eliminate the underlying tendency to develop Crohn’s disease.
Medical treatment and postoperative monitoring may still be needed to reduce recurrence risk.
.jpeg)
